TY  - GEN
AU  - Hussein,A M
AU  - Petros,W P
AU  - Ross,M
AU  - Vredenburgh,J J
AU  - Affrontil,M L
AU  - Jones,R B
AU  - Shpall,E J
AU  - Rubin,P
AU  - Elkordy,M
AU  - Gilbert,C
AU  - Gupton,C
AU  - Egorin,M J
AU  - Soper,J
AU  - Berchuck,A
AU  - Clarke-Person,D
AU  - Berry,D A
AU  - Peters,W P
TI  - A phase I/II study of high-dose cyclophosphamide, cisplatin, and thioTEPA followed by autologous bone marrow and granulocyte colony-stimulating factor-primed peripheral-blood progenitor cells in patients with advanced malignancies
SN  - 0344-5704
PY  - 1996///0606
KW  - Adult
KW  - Bone Marrow Transplantation
KW  - Cisplatin
KW  - administration & dosage
KW  - Combined Modality Therapy
KW  - Cyclophosphamide
KW  - Dose-Response Relationship, Drug
KW  - Female
KW  - Granulocyte Colony-Stimulating Factor
KW  - Humans
KW  - Male
KW  - Middle Aged
KW  - Neoplasms
KW  - therapy
KW  - Thiotepa
N1  - Publication Type: Clinical Trial; Clinical Trial, Phase I; Clinical Trial, Phase II; Journal Article; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, P.H.S
UR  - https://doi.org/10.1007/s002800050429
ER  -